Dose Ranging Study in Healthy Methadone Maintenance Subjects
This study has been completed.
Information provided by:
First received: October 11, 2006
Last updated: July 22, 2011
Last verified: July 2011
To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.
|Study Design:||Allocation: Randomized
Endpoint Classification: Pharmacokinetics/Dynamics Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||A Randomized, Double-blind, 4-period Crossover, Dose-ranging Study to Determine the Effects on the Oral-cecal Transit Time of Single Doses of MOA-728 and the Safety and Tolerability of Multiple Doses of MOA-728 in Stable Methadone Maintenance Subjects|
Resource links provided by NLM:
Further study details as provided by Salix Pharmaceuticals:
Contacts and Locations